Unexpected False-positive I-131 Uptake in Patients with Differentiated Thyroid Carcinoma | Zendy

Aylin Oral | Zendy; Bülent Yazıcı | Zendy; Cenk Eraslan | Zendy; Zeynep Burak | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Unexpected False-positive I-131 Uptake in Patients with Differentiated Thyroid Carcinoma

Author(s) -

Aylin Oral,

Bülent Yazıcı,

Cenk Eraslan,

Zeynep Burak

Publication year - 2018

Publication title -

molecular imaging and radionuclide therapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.292

H-Index - 7

eISSN - 2147-1959

pISSN - 2146-1414

DOI - 10.4274/mirt.37450

Subject(s) - medicine , concomitant , thyroid , radiology , thyroid carcinoma , nuclear medicine , calcification , lung

Radioiodine is the most specific radionuclide for differentiated thyroid carcinoma (DTC) imaging. Despite its high specificity and sensitivity, false-positive I-131 uptake could be seen on whole body scan (WBS) that may lead to misdiagnosis and unnecessary radioiodine treatment. In this study, we aimed to present the I-131 WBS and concomitant single photon emission computed tomography/computed tomography (SPECT/CT) images of unexpected false-positive radioiodine uptake along with the patients’ clinical outcomes and the contribution of SPECT/CT imaging.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research